RT Journal Article
SR Electronic
T1 Long-read nanopore sequencing reveals novel common genetic structural variants in Prader-Willi syndrome and associated psychosis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.18.22277235
DO 10.1101/2022.07.18.22277235
A1 Maximilian Deest
A1 Björn Brändl
A1 Christian Rohrandt
A1 Christian Eberlein
A1 Stefan Bleich
A1 Franz-Josef Müller
A1 Helge Frieling
YR 2022
UL http://medrxiv.org/content/early/2022/07/19/2022.07.18.22277235.abstract
AB Prader-Willi syndrome (PWS) is associated with severe hyperphagia, a specific behavioral phenotype and a high risk for developing psychotic episodes. Despite intense research, how genes within the PWS locus contribute to the phenotype remains elusive. In this study, we sequenced the whole genomes of 20 individuals with PWS using long-read nanopore sequencing by Oxford Nanopore Technologies (ONT). We demonstrate that ONT sequencing can resolve the PWS locus by determining the genetic subtype of PWS. Furthermore, we identified several novel structural variants (SV, >30bp) common in all PWS individuals. We are the first to show that the opioid system and the nociceptin/orphanin FQ system may be affected in PWS due to SVs in OPRM1 and OPRL1. Furthermore, we demonstrate that individuals with PWS, especially those with psychosis, exhibit a high burden of SVs in loci with known associations with bipolar disorder, schizophrenia and autism spectrum disorder. Our results challenge the current hypothesis that the PWS phenotype can be mainly explained by the loss of paternally expressed genes on chr15q11.2-13.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by PRACTIS Clinician Scientist Program of Hannover Medical School, funded by the German Research Foundation (DFG, ME3696/3 1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study adhered to the Declaration of Helsinki and was approved by the local Ethics Committee of Hannover Medical School (Nr. 8129_BO_S_2020), Hannover, Germany.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors